“…Aldose reductase (AR) can be activated by all of the above-mentioned pathways. AR is involved in proliferation of mesangial cells, deposition of extracellular matrix, inflammation, apoptosis, tubular injury and decrease of glomerular filtration rate (Kuo et al, 2006;Efrati et al, 2007;Ding et al, 2010;Zhang et al, 2010;Chang et al, 2011;Masugata et al, 2011), and ultimately result in renal dysfunction (Krzesinski and Cohen, 2007;Barri, 2008;Bidani et al, 2009).…”